Work

Alemtuzumab Achieved Durable Hematologic Response In Heavily Treated T-Large Granular Lymphocytosis Irrespective To STAT3 Mutation Or V-Beta Clone Size

Year: 2013

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v122.21.3705.3705

Authors: Bogdan Dumitriu, Phillip Scheinberg, Sawa Ito, Nicole Stephens, Yunce Muharrem, Emily King, Sachiko Kajigaya, J. Joseph Melenhorst, Fariba Chinian, Keyvan Keyvanfar, Minoo Battiwalla, Pawel Muranski, Neal S. Young, A. John Barrett

Institutions: National Institutes of Health, National Heart, Lung, and Blood Institute, Beneficência Portuguesa de São Paulo, Abramson Cancer Center, University of Pennsylvania

Language: English

Topic: Immunodeficiency and Autoimmune Disorders

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2979909884

FWCI:

Cites:

Cited by:

Related to: 10